Crinetics Pharmaceuticals, Inc. (CRNX)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Crinetics Pharmaceuticals, Inc. chart...

About the Company

We do not have any company description for Crinetics Pharmaceuticals, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

194

Exchange

Nasdaq

$34M

Total Revenue

194

Employees

$3B

Market Capitalization

-11.71

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CRNX News

Crinetics Pharmaceuticals Inc CRNX

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Crinetics Pharmaceuticals Inc CFO Marc Wilson Sells 6,942 Shares

1mon ago, source: Yahoo Finance

Marc Wilson, Chief Financial Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), has sold 6,942 shares of the company on March 19, 2024, according to a recent SEC Filing. The transaction was ...

Crinetics Pharmaceuticals Stock (NASDAQ:CRNX), Analyst Ratings, Price Targets, Predictions

28d ago, source: Benzinga.com

$44.10-4.76% HC Wainwright & Co.

Where Do Analysts Think The Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) Is Going

10d ago, source:

Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) price closed lower on Friday, April 12, dropping -7.16% below its previous close.

Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14d ago, source: Business Insider

SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted ...

Crinetics Pharmaceuticals Inc.

3d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Crinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14d ago, source: Finanznachrichten

SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted ...

Crinetics Pharmaceuticals Inc CRNX

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Crinetics Pharmaceuticals, Inc. (CRNX)

10d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Crinetics Pharmaceuticals Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Crinetics Pharmaceuticals Inc (CRNX)

24d ago, source: Investing

On Wednesday, JPMorgan updated its outlook on Crinetics Pharmaceuticals (NASDAQ:CRNX), raising the price target on the company's shares to $47 from $35, while maintaining an ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...